Climber
Well-known member
Oh, come on now, man, that's just like your opinion. :laughingThat's been the million dollar question BUT pneumonia in July isn't really a thing
Just kidding, always appreciate your input. :thumbup
Oh, come on now, man, that's just like your opinion. :laughingThat's been the million dollar question BUT pneumonia in July isn't really a thing
I'm not a statistician, I'm an analyst. I read what stats provides and I make recommendations. Kinda like the office space joke but I add real value by being able to distill and inform :laughing
Well, it would be better if the TPS reports were timely and accurate....
And have the requisite cover sheet
An NPR investigation has found irregularities in the process by which the Trump administration awarded a multi-million dollar contract to a Pittsburgh company to collect key data about COVID-19 from the country's hospitals.
The contract is at the center of a controversy over the administration's decision to move that data reporting function from the Centers for Disease Control and Prevention — which has tracked infection information for a range of illnesses for years — to the Department of Health and Human Services.
TeleTracking Technologies, the company that won the contract, has traditionally focused on creating software for hospitals to track patient status. And there are questions about how it came to be responsible for gathering data in the midst of a pandemic.
Among the findings of the NPR investigation:
- The Department of Health and Human Services initially characterized the contract with TeleTracking as a no-bid contract. When asked about that, HHS said there was a "coding error" and that the contract was actually competitively bid.
- The process by which HHS awarded the contract is normally used for innovative scientific research, not the building of government databases.
- HHS had directly phoned the company about the contract, according to a company spokesperson.
- TeleTracking CEO Michael Zamagias had links to the New York real estate world — and in particular, a firm that financed billions of dollars in projects with the Trump Organization.
I'm not going to those parts of the web to confirm for myself, but I've heard there's also a black market for covid-19 test results.
I can't really say I'm surprised.
Nearly three dozen current and former members of a federal health advisory committee — including some appointed or reappointed by Health Secretary Alex M. Azar — are warning that the Trump administration’s new coronavirus database is placing an undue burden on hospitals and will have “serious consequences on data integrity.”
The private health care technology vendor that is helping to manage the Trump administration’s new coronavirus database has refused to answer questions from top Senate Democrats about its $10.2 million contract, saying it signed a nondisclosure agreement with the federal Department of Health and Human Services.
In a letter obtained by The New York Times, dated Aug. 3, a lawyer for the Pittsburgh-based TeleTracking Technologies cited the nondisclosure agreement in refusing to provide information about its process for collecting and sharing data; its proposal to the government; communications with White House staff or other officials; and any other information related to the award.
https://int.nyt.com/data/documenttools/tele-tracking-response-to-sentator-schumer-and-senator-murray-dated-august-03-2020-1/7cf488a8cc55487b/full.pdf
They are stalling until after early November.Experts warn that new U.S. rules on virus data collection are creating problems for hospitals and data integrity.
https://www.nytimes.com/2020/08/12/world/coronavirus-covid-19.html#link-e6df5d5
The manager of the Trump administration’s new virus database refuses Senate questioning, citing a nondisclosure agreement.
https://www.nytimes.com/2020/08/14/world/covid-19-coronavirus.html#link-538de6a7